Carrier Screening Market Size, Share & Industry Analysis By Type (Targeted Disease Carrier Screening, Expanded Carrier Screening (ECS), and Custom Panel Screening), By Technology (DNA Sequencing, Polymerase Chain Reaction (PCR), Microarray-based Screening, and Others), By Indication (Hemoglobinopathies, Cystic Fibrosis, Spinal Muscular Atrophy (SMA), Fragile X, and Others), By Sample Type (Blood, Saliva, and Others), By Service Provider (Clinical Laboratories, Hospital Laboratories, Direct-to-Consumer (DTC) Testing Companies, and Others), and Regional Forecast, 2026-2034

Last Updated: December 24, 2025 | Format: PDF | Report ID: FBI114944

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2025
2. Advancements in the Carrier Screening Market
3. New Service Launches, Key Players
4. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Technology
  2. Canada
    1. By Technology
Europe Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Technology
  2. Germany
    1. By Technology
  3. France
    1. By Technology
  4. Spain
    1. By Technology
  5. Italy
    1. By Technology
  6. Scandinavia
    1. By Technology
  7. Rest of Europe
    1. By Technology
Asia Pacific Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Technology
  2. Australia
    1. By Technology
  3. China
    1. By Technology
  4. India
    1. By Technology
  5. Southeast Asia
    1. By Technology
  6. Rest of Asia Pacific
    1. By Technology
Latin America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Technology
  2. Mexico
    1. By Technology
  3. Rest of Latin America
    1. By Technology
Middle East & Africa Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Technology
  2. South Africa
    1. By Technology
  3. Rest of Middle East & Africa
    1. By Technology
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Natera, Inc.
  2. Labcorp
  3. Quest Diagnostics Incorporated.
  4. Myriad Genetics, Inc.
  5. Fulgent Genetics
  6. BGI Group
  7. Berry Genomics
  8. Eurofins Scientific
  9. CENTOGENE GmbH
  10. YOURGENE HEALTH
  11. MedGenome

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Disorders, Key Countries/Regions, 2025/2025
2. Advancements in the Carrier Screening Market
3. New Service Launches, Key Players
4. Key Industry Developments - Mergers, Acquisitions & Partnerships
Global Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Technology
  2. Canada
    1. By Technology
Europe Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Technology
  2. Germany
    1. By Technology
  3. France
    1. By Technology
  4. Spain
    1. By Technology
  5. Italy
    1. By Technology
  6. Scandinavia
    1. By Technology
  7. Rest of Europe
    1. By Technology
Asia Pacific Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
    1. By Technology
  2. Australia
    1. By Technology
  3. China
    1. By Technology
  4. India
    1. By Technology
  5. Southeast Asia
    1. By Technology
  6. Rest of Asia Pacific
    1. By Technology
Latin America Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
    1. By Technology
  2. Mexico
    1. By Technology
  3. Rest of Latin America
    1. By Technology
Middle East & Africa Carrier Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Targeted Disease Carrier Screening
  2. Expanded Carrier Screening (ECS)
  3. Custom Panel Screening
2. Market Analysis, Insights and Forecast – By Technology
  1. Next-Generation Sequencing (NGS)
  2. Polymerase Chain Reaction (PCR)
  3. Microarray-based Screening
  4. Other Technologies
3. Market Analysis, Insights and Forecast – By Indication
  1. Hemoglobinopathies
  2. Cystic Fibrosis
  3. Spinal Muscular Atrophy (SMA)
  4. Fragile X
  5. Others
4. Market Analysis, Insights and Forecast – By Sample Type
  1. Blood
  2. Saliva
  3. Others
5. Market Analysis, Insights and Forecast – By Service Provider
  1. Clinical Laboratories
  2. Hospital Laboratories
  3. Direct-to-Consumer (DTC) Testing Companies
  4. Others
6. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
    1. By Technology
  2. South Africa
    1. By Technology
  3. Rest of Middle East & Africa
    1. By Technology
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability)
  1. Natera, Inc.
  2. Labcorp
  3. Quest Diagnostics Incorporated.
  4. Myriad Genetics, Inc.
  5. Fulgent Genetics
  6. BGI Group
  7. Berry Genomics
  8. Eurofins Scientific
  9. CENTOGENE GmbH
  10. YOURGENE HEALTH
  11. MedGenome

Read Less

List of Figures

Figure 1: Global Carrier Screening Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Carrier Screening Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Carrier Screening Market Value Share (%), By Technology, 2025 & 2034

Figure 4: Global Carrier Screening Market Value Share (%), by Indication, 2025 & 2034

Figure 5: Global Carrier Screening Market Value Share (%), by Sample Type, 2025 & 2034

Figure 6: Global Carrier Screening Market Value Share (%), by Service Provider, 2025 & 2034

Figure 7: Global Carrier Screening Market Value Share (%), by Region, 2025 & 2034

Figure 8: North America Carrier Screening Market Value (USD billion), by Type, 2025 & 2034

Figure 9: North America Carrier Screening Market Value Share (%), by Type, 2025

Figure 10: North America Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034

Figure 11: North America Carrier Screening Market Value Share (%), By Technology, 2025

Figure 12: North America Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034

Figure 13: North America Carrier Screening Market Value Share (%), by Indication, 2025

Figure 14: North America Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 15: North America Carrier Screening Market Value Share (%), by Sample Type, 2025

Figure 16: North America Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034

Figure 17: North America Carrier Screening Market Value Share (%), by Service Provider, 2025

Figure 18: North America Carrier Screening Market Value (USD billion), By Country, 2025 & 2034

Figure 19: North America Carrier Screening Market Value Share (%), By Country, 2025

Figure 20: Europe Carrier Screening Market Value (USD billion), by Type, 2025 & 2034

Figure 21: Europe Carrier Screening Market Value Share (%), by Type, 2025

Figure 22: Europe Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034

Figure 23: Europe Carrier Screening Market Value Share (%), By Technology, 2025

Figure 24: Europe Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034

Figure 25: Europe Carrier Screening Market Value Share (%), by Indication, 2025

Figure 26: Europe Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 27: Europe Carrier Screening Market Value Share (%), by Sample Type, 2025

Figure 28: Europe Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034

Figure 29: Europe Carrier Screening Market Value Share (%), by Service Provider, 2025

Figure 30: Europe Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 31: Europe Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025

Figure 32: Asia Pacific Carrier Screening Market Value (USD billion), by Type, 2025 & 2034

Figure 33: Asia Pacific Carrier Screening Market Value Share (%), by Type, 2025

Figure 34: Asia Pacific Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034

Figure 35: Asia Pacific Carrier Screening Market Value Share (%), By Technology, 2025

Figure 36: Asia Pacific Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034

Figure 37: Asia Pacific Carrier Screening Market Value Share (%), by Indication, 2025

Figure 38: Asia Pacific Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 39: Asia Pacific Carrier Screening Market Value Share (%), by Sample Type, 2025

Figure 40: Asia Pacific Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034

Figure 41: Asia Pacific Carrier Screening Market Value Share (%), by Service Provider, 2025

Figure 42: Asia Pacific Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 43: Asia Pacific Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025

Figure 44: Latin America Carrier Screening Market Value (USD billion), by Type, 2025 & 2034

Figure 45: Latin America Carrier Screening Market Value Share (%), by Type, 2025

Figure 46: Latin America Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034

Figure 47: Latin America Carrier Screening Market Value Share (%), By Technology, 2025

Figure 48: Latin America Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034

Figure 49: Latin America Carrier Screening Market Value Share (%), by Indication, 2025

Figure 50: Latin America Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 51: Latin America Carrier Screening Market Value Share (%), by Sample Type, 2025

Figure 52: Latin America Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034

Figure 53: Latin America Carrier Screening Market Value Share (%), by Service Provider, 2025

Figure 54: Latin America Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 55: Latin America Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025

Figure 56: Middle East & Africa Carrier Screening Market Value (USD billion), by Type, 2025 & 2034

Figure 57: Middle East & Africa Carrier Screening Market Value Share (%), by Type, 2025

Figure 58: Middle East & Africa Carrier Screening Market Value (USD billion), By Technology, 2025 & 2034

Figure 59: Middle East & Africa Carrier Screening Market Value Share (%), By Technology, 2025

Figure 60: Middle East & Africa Carrier Screening Market Value (USD billion), by Indication, 2025 & 2034

Figure 61: Middle East & Africa Carrier Screening Market Value Share (%), by Indication, 2025

Figure 62: Middle East & Africa Carrier Screening Market Value (USD billion), by Sample Type, 2025 & 2034

Figure 63: Middle East & Africa Carrier Screening Market Value Share (%), by Sample Type, 2025

Figure 64: Middle East & Africa Carrier Screening Market Value (USD billion), by Service Provider, 2025 & 2034

Figure 65: Middle East & Africa Carrier Screening Market Value Share (%), by Service Provider, 2025

Figure 66: Middle East & Africa Carrier Screening Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 67: Middle East & Africa Carrier Screening Market Value Share (%), By Country/ Sub-region, 2025

Figure 68: Global Carrier Screening Market Share (%), By Company, 2025

List of Tables

Table 1: Global Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 2: Global Carrier Screening Market Revenue (USD billion) Forecast, by Technology, 2021–2034

Table 3: Global Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 4: Global Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 5: Global Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 6: Global Carrier Screening Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 7: North America Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 8: North America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 9: North America Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 10: North America Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 11: North America Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 12: North America Carrier Screening Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 13: U.S. Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 14: Canada Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 15: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 16: Europe Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 17: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 18: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 19: Europe Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 20: Europe Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 21: Germany Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 22: U.K. Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 23: France Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 24: Italy Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 25: Spain Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 26: Scandinavia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 27: Rest of Europe Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 28: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 29: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 30: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 31: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 32: Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 33: China Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 34: Japan Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 35: India Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 36: Australia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 37: Southeast Asia Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 38: Rest of Asia Pacific Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 39: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 40: Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 41: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 42: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 43: Latin America Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 44: Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 45: Brazil Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 46: Mexico Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 47: Rest of Latin America Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 48: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 49: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 50: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Indication, 2021–2034

Table 51: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Sample Type, 2021–2034

Table 52: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, by Service Provider, 2021–2034

Table 53: Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 54: GCC Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 55: South Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

Table 56: Rest of Middle East & Africa Carrier Screening Market Revenue (USD billion) Forecast, By Technology, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 260

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com